Phase 1 Cardiomyopathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have liver cirrhosis and are being considered for a liver transplant, with no medical reasons ruling out transplantation
- Women who have gone through menopause at least 24 months ago, have had a surgical procedure that prevents pregnancy, or are using an effective form of contraception (such as the pill, contraceptive injections, an IUD, a contraceptive patch, or a double-barrier method)
- People who have read, understood, and signed a consent form agreeing to take part in the study and follow its requirements
- People who are covered by, or are a beneficiary of, a social security system
Who may not be able to join:
- People under 18 years old or over 70 years old
- People who have already received a liver transplant
- People who have a TIPS (a shunt placed in the liver to manage blood pressure — confirm with trial site if unsure)
- People with known heart conditions, including high blood pressure in the lungs related to liver disease, history of coronary artery disease with heart muscle damage, or a history of heart muscle disease or inflammation
- People with uncontrolled high blood pressure and a thickened heart wall (a specific measurement of ≥15mm — confirm with trial site)
- People who are in a state of haemodynamic instability (meaning the body is struggling to maintain stable blood circulation — confirm with trial site)
- People with Type 1 diabetes
- People with an active bacterial infection at the time of the trial
- People with HIV infection, or whose HIV status is unknown
- People who cannot have an MRI scan, including those with pacemakers, implanted defibrillators, certain metal implants or clips, insulin pumps, certain types of heart valves, eye or ear implants, metal fragments in the eyes, severe kidney problems, inability to hold their breath briefly, claustrophobia, or a known contraindication to contrast dye used in imaging
- People with severe brain complications from liver disease (hepatic encephalopathy) who are unable to understand information and do not have a trusted representative to assist them
- People under legal guardianship or who have limited legal capacity
- People who are currently detained or deprived of their liberty
- Women who are pregnant or breastfeeding
- People the trial investigators believe are unlikely to cooperate with the study requirements
- People currently enrolled in another clinical trial or listed in a national register that prevents participation in additional studies
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Thierry THEVENOT, MD, PHD, Centre Hospitalier Universitaire de Besancon
Phone: +33381669457
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Primary outcome measure
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.